Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Endocrinology · Toxic Multinodular Goiter

Can Toxic Multinodular Goiter Increase Heart or Bone Risks?

At a Glance

Toxic multinodular goiter can raise the risk of an irregular heartbeat, heart strain, bone loss, and fractures when thyroid-stimulating hormone stays very low. The risk is not certain and depends on your age, health history, and how long the level remains suppressed.

Yes. Having a toxic multinodular goiter can increase the risk of developing heart and bone complications, even if your daily symptoms feel mild [1][2]. However, this is an increased risk, not a certainty. The actual risk to your heart and bones depends heavily on your age, your individual medical history, and exactly how suppressed your thyroid hormone levels are.

In this context, the word toxic simply means that the nodules in your thyroid are producing hormone independently—it does not mean they are poisonous [3]. This independent production often results in subclinical hyperthyroidism, a state where your main thyroid hormones (Free T4 and Free T3) are normal, but your brain’s stimulating hormone (TSH) drops lower than normal because it senses there is enough thyroid hormone in the blood [4][5].

TSH Levels and Your Risk

Not all low TSH levels carry the same risks. The degree and duration of your TSH suppression matter significantly:

  • Mildly low TSH (0.1 to 0.4 mIU/L): This often carries a lower immediate risk. Your doctor may choose to simply monitor your levels closely.
  • Fully suppressed TSH (less than 0.1 mIU/L): If your TSH is persistently suppressed below this level, the long-term risks to your heart and bones are higher [1][4][6].

Because an isolated low TSH can be caused by acute illness, certain medications, or supplements (like biotin), a single blood test is rarely enough. Your doctor will likely repeat your blood tests to confirm if the condition is persistent [4].

“Apathetic Hyperthyroidism” in Older Adults

In younger people, an overactive thyroid often causes extreme anxiety, sweating, or tremors. In older adults, the condition frequently presents as apathetic hyperthyroidism [7][8]. Instead of feeling “hyper,” you might experience unexplained fatigue, muscle weakness, weight loss, or mental sluggishness [7][9][10]. While these symptoms have many possible causes and don’t necessarily prove there is hidden thyroid damage, they can sometimes mask an underlying thyroid issue, leading people to brush them off as “just getting older” [11].

Potential Heart Complications

Excess thyroid hormone increases the heart’s workload. Persistent thyroid overactivity, especially a fully suppressed TSH, can lead to:

  • Atrial Fibrillation (AFib): A fast, irregular heartbeat. Subclinical hyperthyroidism significantly increases the risk of AFib, particularly in adults over 65 [1][2].
  • Tachycardia: A fast resting heart rate, which can aggravate abnormal heart rhythms or worsen angina (chest pain) in susceptible people [12].
  • Heart Failure: In people with existing heart disease, persistent excess thyroid hormone may contribute to heart failure [13][14].

Because of these associations, guidelines suggest doctors strongly consider treatment for adults over 65 whose TSH is persistently below 0.1 mIU/L [1][15].

Potential Bone and Muscle Complications

Thyroid hormones directly influence how quickly the body breaks down and rebuilds bone.

  • Bone Loss: Excess hormone can increase bone turnover, potentially reducing bone mineral density over time [16]. This can contribute to osteopenia or osteoporosis, particularly in postmenopausal women [2].
  • Fracture Risk: For those with persistently suppressed TSH (<0.1 mIU/L), accelerated bone turnover is linked to a higher risk of bone fractures [1][17].
  • Muscle Weakness: Toxic multinodular goiter can sometimes cause weakness in the muscles, particularly in the thighs and upper arms [18].

Medical Evaluation and Next Steps

Your clinician will individualize your tests based on your age, symptoms, and specific risks. A typical evaluation includes:

  • Repeat Blood Tests: Confirming TSH, Free T4, and Free T3 to see if the suppression is persistent [4][19].
  • Imaging: An ultrasound or a radionuclide thyroid scan to confirm which nodules are overproducing hormone [20][3].
  • Heart Assessment: An ECG (electrocardiogram) to check your heart’s rhythm. If you have intermittent palpitations, your doctor might recommend an ambulatory monitor (like a Holter monitor), as a standard ECG only captures a few seconds of heart activity and can miss intermittent AFib [14][11].
  • Bone Health Evaluation: A DEXA scan (bone density test), typically guided by your age, menopausal status, and how long your TSH has been suppressed [16][17].

Treatment Options

Depending on your TSH level, goiter size, and heart or bone risks, management is tailored to you. Options include observation (active monitoring), radioactive iodine therapy, anti-thyroid medications, or surgery [15][3]. Your doctor will help balance the risks of medical treatment against the risks of leaving the goiter untreated.

When to Seek Urgent Medical Care

While mild thyroid overactivity usually progresses slowly, it can trigger sudden heart issues in susceptible people. Seek immediate medical attention if you experience:

  • Sudden, severe breathlessness
  • Chest pain or pressure
  • Fainting or extreme dizziness
  • A very fast or highly irregular heartbeat that doesn’t settle down
  • Signs of a stroke: such as facial drooping, arm weakness, or difficulty speaking (Atrial fibrillation can increase stroke risk).

Common questions in this guide

What heart problems can toxic multinodular goiter cause?
Ongoing thyroid overactivity can increase the chance of atrial fibrillation, a fast and irregular heart rhythm, and can cause a fast resting pulse or worsen chest pain in susceptible people. In people who already have heart disease, it may also contribute to heart failure. The risk is higher when TSH remains below 0.1 mIU/L, especially in adults over 65.
Can toxic multinodular goiter lead to osteoporosis or broken bones?
Yes, persistent thyroid overactivity can speed up bone turnover and reduce bone mineral density. Over time this may contribute to osteopenia, osteoporosis, and fractures, particularly in postmenopausal women or people whose TSH stays below 0.1 mIU/L.
Does every low TSH result mean I have a high risk of complications?
No. A mildly low TSH of 0.1 to 0.4 mIU/L often carries less immediate risk than a TSH below 0.1 mIU/L that remains suppressed. Doctors usually repeat TSH and free thyroid hormone tests because illness, medicines, and supplements such as biotin can temporarily affect the result.
What tests check whether my heart or bones are being affected?
Repeat blood tests can confirm whether low TSH persists and measure free T4 and free T3. An ECG checks heart rhythm, and an ambulatory monitor may detect intermittent atrial fibrillation or other rhythm problems. A DEXA scan measures bone density and may be considered based on your age, menopausal status, and how long TSH has been suppressed.
How is toxic multinodular goiter treated when heart or bone risks are present?
Treatment is individualized based on TSH level, goiter size, age, and heart or bone risks. Options include active monitoring, antithyroid medicines, radioactive iodine, and surgery. Your clinician weighs the risks of each option against the risks of leaving thyroid overactivity untreated.
Can hyperthyroidism be easy to miss in an older adult?
Yes. Older adults may have apathetic hyperthyroidism, with fatigue, muscle weakness, weight loss, or mental sluggishness instead of obvious anxiety, sweating, or tremors. These symptoms have many possible causes, so blood tests are needed to determine whether thyroid overactivity is involved.

Get notified when new evidence is published on multinodular goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.

    Biondi B, Bartalena L, Cooper DS, et al.

    European thyroid journal 2015; (4(3)):149-63 doi:10.1159/000438750.

    PMID: 26558232
  2. 2

    Subclinical Hyperthyroidism: When to Consider Treatment.

    Donangelo I, Suh SY

    American family physician 2017; (95(11)):710-716.

    PMID: 28671443
  3. 3

    2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

    Ross DS, Burch HB, Cooper DS, et al.

    Thyroid : official journal of the American Thyroid Association 2016; (26(10)):1343-1421 doi:10.1089/thy.2016.0229.

    PMID: 27521067
  4. 4

    Hyperthyroidism: A Review.

    Lee SY, Pearce EN

    JAMA 2023; (330(15)):1472-1483 doi:10.1001/jama.2023.19052.

    PMID: 37847271
  5. 5

    The role of laboratory medicine in the diagnosis of the hyperthyroidism.

    D'Aurizio F

    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2021; (65(2)):91-101 doi:10.23736/S1824-4785.21.03344-6.

    PMID: 33565846
  6. 6

    Considerations in the Diagnosis and Management of Thyroid Dysfunction in Older Adults.

    Jasim S, Papaleontiou M

    Thyroid : official journal of the American Thyroid Association 2025; (35(6)):624-632 doi:10.1089/thy.2025.0128.

    PMID: 40376729
  7. 7

    Apathetic hyperthyroidism in an elderly patient presenting with psychomotor retardation.

    Delacroix R, Umberger JM

    Journal of the American Association of Nurse Practitioners 2022; (34(9)):1098-1102 doi:10.1097/JXX.0000000000000767.

    PMID: 36083321
  8. 8

    Atrial Fibrillation as an Initial Presentation of Apathetic Thyroid Storm.

    Ali H, Sarfraz S, Hassan L, Ali H

    Cureus 2021; (13(9)):e17786 doi:10.7759/cureus.17786.

    PMID: 34659997
  9. 9

    Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation.

    Chiera M, Draghetti S, De Ronchi D, et al.

    International clinical psychopharmacology 2023; (38(4)):269-272 doi:10.1097/YIC.0000000000000438.

    PMID: 36853810
  10. 10

    The association between subclinical thyroid dysfunction and dementia: The Health, Aging and Body Composition (Health ABC) Study.

    Aubert CE, Bauer DC, da Costa BR, et al.

    Clinical endocrinology 2017; (87(5)):617-626 doi:10.1111/cen.13458.

    PMID: 28850708
  11. 11

    Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.

    Goichot B, Caron P, Landron F, Bouée S

    Clinical endocrinology 2016; (84(3)):445-51 doi:10.1111/cen.12816.

    PMID: 25959282
  12. 12

    Treatment of subclinical hyperthyroidism: effect on left ventricular mass and function of the heart using magnetic resonance imaging technique.

    Mark PD, Andreassen M, Petersen CL, et al.

    Endocrine connections 2015; (4(1)):37-42 doi:10.1530/EC-14-0137.

    PMID: 25568332
  13. 13

    Acute Decompensated Heart Failure in an Elderly Patient: A Rare Presentation of Toxic Nodular Goiter.

    Lin TC, Kornelius E

    The American journal of case reports 2025; (26()):e947896 doi:10.12659/AJCR.947896.

    PMID: 40202927
  14. 14

    Cardiothyreosis: Prevalence and risk factors.

    Yazidi M, Chihaoui M, Oueslati H, et al.

    Annales d'endocrinologie 2019; (80(4)):211-215 doi:10.1016/j.ando.2017.11.004.

    PMID: 31235068
  15. 15

    Subclinical Hyperthyroidism and the Cardiovascular Disease.

    Delitala AP

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2017; (49(10)):723-731 doi:10.1055/s-0043-117893.

    PMID: 28915531
  16. 16

    Mechanisms and Treatment Options for Hyperthyroid-Induced Osteoporosis: A Narrative Review.

    Branstetter RM, Islam RK, Toups CA, et al.

    Cureus 2023; (15(11)):e48798 doi:10.7759/cureus.48798.

    PMID: 38098934
  17. 17

    Thyroid and Parathyroid Conditions: Hyperthyroidism.

    Rhodes MA, Adams CS, Bragg S, Christian N

    FP essentials 2022; (514()):11-17.

    PMID: 35235281
  18. 18

    Hyperthyroidism: Diagnosis and Treatment.

    Mounsey A, Paulus R, Roten W

    American family physician 2025; (112(2)):146-152.

    PMID: 40834371
  19. 19

    Hyperthyroidism.

    Chaker L, Cooper DS, Walsh JP, Peeters RP

    Lancet (London, England) 2024; (403(10428)):768-780 doi:10.1016/S0140-6736(23)02016-0.

    PMID: 38278171
  20. 20

    Thyroid nodules: diagnosis and management.

    Wong R, Farrell SG, Grossmann M

    The Medical journal of Australia 2018; (209(2)):92-98 doi:10.5694/mja17.01204.

    PMID: 29996756

This page explains possible heart and bone complications of toxic multinodular goiter for informational purposes only and does not constitute medical advice. Ask your clinician to interpret your thyroid results and decide whether heart or bone testing or treatment is appropriate for you.